A report of 42 patients with type Ⅲ biliary atresia treated by hepatojejunostomy / 中华肝胆外科杂志
Chinese Journal of Hepatobiliary Surgery
; (12): 548-550, 2015.
Article
en Zh
| WPRIM
| ID: wpr-478505
Biblioteca responsable:
WPRO
ABSTRACT
Objective To determine the clinical effects of type Ⅲ biliary atresia treated by hepatojejunostomy (Kasai procedure).Methods A retrospective study was performed on patients with type Ⅲ biliary atresia treated in our hospital between January 2009 to December 2013.Results The follow-up data were completed in 42 patients out of 48 patients (87.5%) who underwent Kasai procedure for type Ⅲ biliary atresia.The jaundice disappeared in 31 of 42 patients (73.8%).The rate of patients having cholangitis was 47.6%.There were significant differences in the 2-year survival among the groups of patients with mild cholangitis (75.0%,9/12),serious cholangitis (25.0%,2/8) and without cholangitis (86.4%,19/22) (P < 0.05).Conclusions Hepatojejunostomy (Kasai procedure) is an effective operation to treat type Ⅲ biliary atresia.Our data suggested that the survival rates were related to the degree of bile drainage and cholangitis post surgery.
Texto completo:
1
Base de datos:
WPRIM
Tipo de estudio:
Observational_studies
Idioma:
Zh
Revista:
Chinese Journal of Hepatobiliary Surgery
Año:
2015
Tipo del documento:
Article